Skip to Content

JKI 11 (Xeljanz XR 11 mg)

Generic Name: tofacitinib

Pill with imprint JKI 11 is Pink, Elliptical / Oval and has been identified as Xeljanz XR 11 mg. It is supplied by Pfizer Inc..

Xeljanz XR is used in the treatment of rheumatoid arthritis; ulcerative colitis; psoriatic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz XR 11 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for JKI 11

Xeljanz XR

Generic Name
tofacitinib
Imprint
JKI 11
Strength
11 mg
Color
Pink
Size
8.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antirheumatics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0501
Inactive Ingredients
sorbitol, hydroxyethyl cellulose (140 mpa.s at 5%), copovidone, magnesium stearate, cellulose acetate, titanium dioxide, hypromellose 2910 (6 mPa.s), triacetin, ferric oxide red, shellac, ammonia, propylene glycol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "JKI 11"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.